Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

W2O taps Tom Richards as creative leader of 21GRAMS

Richards joins as co-global chief creative officer

Article: Pricing a coronavirus vaccine

Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine. Read...

Inizio

News: Living with Ulcerative Colitis and Crohn’s Disease

Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports...

Inizio

- PMLiVE

NICE recommends Astellas’ Xospata for NHS use

Cost-effectiveness watchdog backtracks on previous rejection

- PMLiVE

AstraZeneca’s Farxiga scores another FDA fast-track designation

Company is aiming for approval in prevention indication

- PMLiVE

Merck, Bayer get FDA priority review for heart failure drug

Target action date set for January 2021

Forging innovative solutions by merging art and science

In the latest episode of Impetus Digital's Fireside Chat, we dive into the concept of merging art and science with Ariel Garten, Founder & Chief Evangelism Officer at Muse. Ariel...

Impetus Digital

Session 3: Systems Innovation Examples and Process

In this session, we discussed the processes involved in systems innovation and reviewed a few examples. We examined the transformational changes that can evolve over time when we go beyond...

Impetus Digital

AstraZeneca AZ

AstraZeneca’s Brilinta reduces rate of secondary stroke

Drug helps to prevent rate of stroke and death by 17%

- PMLiVE

Novartis reveals plans for a zero-profit COVID-19 drugs portfolio

Includes 15 medicines from company's generics division

PoTS LIVE

PoTS LIVE: A unique ethnography study in rare disease

Digital ethnography has been deployed with PoTS patients for the first time, by Origins Insights, with significant results for the PoTS UK charity.

Bedrock Healthcare Communications

- PMLiVE

Healthineers’ COVID-19 antibody test proves most effective in comparative study

Beats tests from Roche, Abbott and DiaSorin

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links